BCL2 and acute lymphoblastic leukemia: The JAK inhibitor TG101209 decreased the JAK/STAT pathway and then down-regulated BCL2, which was the key effect in the crosstalk between apoptosis and autophagy; thus, this cascade inhibited the up-regulation of autophagy, decreased the proliferation of T-ALL cells and increased their apoptosis.